GlassScriptPhysician profile
Jared S Hollinger
NPI 1861871097
$2,207.37
in general payments reported to CMS, 2019-2025
17 companies · $1,407 in 2025
The $1,407 reported for 2025 was more than what a typical Neuromuscular Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $530).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $49.77 · 2023: $102 · 2024: $532 · 2025: $1,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,007 · Education: $34.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,007.03 |
| Education | $34.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $880.07 | 2022-2025 | |
| Argenx US, INC. | $485.82 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Ucb, INC. | $160.93 | 2025 | Rystiggo |
| Neurelis, INC. | $152.90 | 2023-2025 | Valtoco |
| Merz Pharmaceuticals, LLC | $85.89 | 2025 | Xeomin, Inbrija, Ampyra |
| Neurocrine Biosciences, INC. | $70.64 | 2024-2025 | Ingrezza |
| Alexion Pharmaceuticals, INC. | $68.24 | 2022-2023 | Ultomiris |
| Biogen, INC. | $57.15 | 2021 | |
| Amgen INC. | $53.09 | 2021-2025 | Uplizna |
| Acadia Pharmaceuticals INC | $41.59 | 2025 | Daybue, Nuplazid |
| Sunovion Pharmaceuticals INC. | $27.58 | 2021 | |
| Sk Life Science, INC. | $25.33 | 2025 | |
| Xeris Pharmaceuticals, INC. | $20.77 | 2025 | Keveyis |
| Tg Therapeutics, INC. | $20.61 | 2024 | |
| Globus Medical, INC. | $20.39 | 2025 | Senza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19.12 | 2021 | |
| Lundbeck LLC | $17.25 | 2025 | Vyepti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Hollinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.